NO20070521L - Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40 - Google Patents

Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40

Info

Publication number
NO20070521L
NO20070521L NO20070521A NO20070521A NO20070521L NO 20070521 L NO20070521 L NO 20070521L NO 20070521 A NO20070521 A NO 20070521A NO 20070521 A NO20070521 A NO 20070521A NO 20070521 L NO20070521 L NO 20070521L
Authority
NO
Norway
Prior art keywords
gpr40
single nucleotide
nucleotide polymorphism
coupled receptor
protein coupled
Prior art date
Application number
NO20070521A
Other languages
English (en)
Inventor
Poulabi Banerjee
Karen Lynne Houseknecht
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20070521L publication Critical patent/NO20070521L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Denne oppfinnelsen er relatert til fremgangsmåter av genotyping, fremgangsmåter for behandling, diagnostiske tester og fremgangsmåter for å karakterisere et middel, relatert til en enkel nukleotid polymorfisme av GPR40-genet.
NO20070521A 2004-06-30 2007-01-26 Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40 NO20070521L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58468604P 2004-06-30 2004-06-30
US11/046,020 US20060003344A1 (en) 2004-06-30 2005-01-28 Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
PCT/IB2005/001962 WO2006006062A1 (en) 2004-06-30 2005-06-20 Methods related to a single nucleotide polymorphism of the g protein coupled receptor, gpr40

Publications (1)

Publication Number Publication Date
NO20070521L true NO20070521L (no) 2007-01-26

Family

ID=35514424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070521A NO20070521L (no) 2004-06-30 2007-01-26 Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40

Country Status (10)

Country Link
US (1) US20060003344A1 (no)
EP (1) EP1763585A1 (no)
JP (1) JP2008504836A (no)
AU (1) AU2005261437A1 (no)
BR (1) BRPI0512745A (no)
CA (1) CA2570921A1 (no)
IL (1) IL179911A0 (no)
MX (1) MXPA06014024A (no)
NO (1) NO20070521L (no)
WO (1) WO2006006062A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
JP5299810B2 (ja) * 2004-02-27 2013-09-25 アムジエン・インコーポレーテツド 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法
US7465804B2 (en) * 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
WO2007033002A1 (en) * 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
CA2646430A1 (en) * 2006-03-14 2007-09-20 Amgen Inc. Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
AU2007292816B2 (en) * 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
CA2662305C (en) * 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
JP2008195625A (ja) * 2007-02-08 2008-08-28 Pharma Frontier Kk Ｇ蛋白質共役型レセプター抑制剤および医薬
EP2139843B1 (en) * 2007-04-16 2013-12-25 Amgen, Inc Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
CN102083783A (zh) 2007-10-10 2011-06-01 安姆根有限公司 取代的联苯gpr40调节剂
WO2009111056A1 (en) * 2008-03-06 2009-09-11 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
AU2009303475B2 (en) * 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
EP3068783B1 (en) 2013-11-15 2020-09-23 The Board of Trustees of the Leland Stanford Junior University Agonists of hypocretin receptor 2 for use for treating heart failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031527D0 (en) * 2000-12-22 2001-02-07 Smithkline Beecham Plc New use
WO2003068959A1 (fr) * 2002-02-14 2003-08-21 Takeda Chemical Industries, Ltd. Nouveau procede de criblage

Also Published As

Publication number Publication date
CA2570921A1 (en) 2006-01-19
BRPI0512745A (pt) 2008-04-08
MXPA06014024A (es) 2007-02-08
AU2005261437A1 (en) 2006-01-19
JP2008504836A (ja) 2008-02-21
WO2006006062A1 (en) 2006-01-19
EP1763585A1 (en) 2007-03-21
US20060003344A1 (en) 2006-01-05
IL179911A0 (en) 2007-05-15

Similar Documents

Publication Publication Date Title
NO20070521L (no) Fremgangsmater relatert til en enkel nukleotid polymorfisme av den G-proteinkoplede reseptor, GPR40
NO20092023L (no) Oligoribonuleotider og anvendelser derav
MX343863B (es) Conjunto de sondas de oligonucleotido y metodos para perfilado de microbiotica.
GB2457402B (en) Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
NO20081883L (no) Modulasjon av glukokortikoidreseptorekspresjon
CY1108829T1 (el) Ενεργοποιηση ace2 για θεραπεια καρδιακης, πνευμονικης και νεφρικης ασθενειας και υπερτασης
TW200608961A (en) Methods and reagents for the treatment of metabolic disorders
DK1520039T3 (da) Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibrose
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
NO20083204L (no) Kombinasjon av en H3-antagonist/inversagonist og en appetittdemper
NO20070949L (no) Transkriptomdiagnostikk i spytt
MX2007009809A (es) Amplificacion de sonda por seleccion.
WO2007047408A3 (en) Promac signature application
WO2008073895A3 (en) Methods and devices for testing saliva
ZA200706670B (en) Method for determining responsiveness to CHK1 inhibitors
NO20073369L (no) Modulatorer av muskarinreseptorer
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
WO2008011484A3 (en) Nicotinic desensitizers and methods of selecting, testing, and using them
NO20082410L (no) Biomarkorer for anti-nogo-a antistoffbehandling ved spinalstrengskader
ATE526585T1 (de) Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon
DE602004030367D1 (de) Diagnostikum für osteoporose
WO2007058968A3 (en) Gene expression profiles and methods of use
NO20070780L (no) Celloverflateprotein.
WO2005056839A3 (de) Primer und sonden zum nachweis genitaler hpv-genotypen
ATE470153T1 (de) Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application